Research Paper Volume 15, Issue 20 pp 11389—11411
Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma
Figure 9. Drug sensitivity analysis between the ICDRG score subtypes. (A–D) IPS evaluation shows the response to PD-1 and CTLA-4 of GC in ICDRG score subtypes. (E–P) Prediction of chemotherapy drug for GC in ICDRG score subgroups.